Loading organizations...
Nature and food-based science for healthier consumer products.
Seraphina Therapeutics has raised $11.2M across 2 funding rounds.
Seraphina Therapeutics has raised $11.2M in total across 2 funding rounds.
Seraphina Therapeutics has raised $11.2M in total across 2 funding rounds.
Seraphina Therapeutics's investors include Larry Segall, Mats Lederhausen, Domain Associates, Daniel M. Bradbury.
Seraphina Therapeutics has raised $11.2M across 2 funding rounds. Most recently, it raised $5.0M Series A Extension in October 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 13, 2021 | $5.0M Series A Extension | Larry Segall, Mats Lederhausen, Domain Associates | Daniel M. Bradbury |
| Jan 4, 2021 | $6.2M Series A |